TRIALTROVE
LIVE

Serial Number

79104037

Owner

Informa UK Limited

Attorney

William C. Wright

Filing Date

Mar 31, 2011

Add to watchlist:

No watchlists yet
View on USPTO

TRIALTROVE Trademark

Serial Number: 79104037 • Registration: 4405071

TRIALTROVE is a trademark filed by Informa UK Limited on March 31, 2011. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Informa UK Limited (69 trademarks)

5 Howick Place
London SW1P1WG , GB

Entity Type: 11

Pharma Intelligence U.K. Limited

3 More London Riverside

Entity Type: 99

Trademark Details

Filing Date

March 31, 2011

Registration Date

September 24, 2013

Published for Opposition

July 9, 2013

Goods & Services

[ Apparatus for recording, transmission or reproduction of sound or images; blank magnetic data carriers, prerecorded magnetic data carriers featuring information and data in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; blank recording optical discs; pre-recorded CDs, video tapes, laser disks and DVDs featuring information in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; downloadable computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare and manuals in electronic format sold as a unit; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; ] downloadable electronic publications in the nature of [ newsletters, ] reports, directories and bulletins in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare from databases or the internet; downloadable electronic publications, namely, [ newsletters, ] reports, directories and bulletins in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare provided on-line from databases or the internet [ ; computer programs featuring programming languages in electronic form for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; prerecorded magnetic, electronic or optical data carriers featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; electronic publications, namely, instruction manuals recorded on computer media relating to use of computers and to data, all recorded magnetically, optically or electronically; magnetic, optical and electronic data recording apparatus for recording of sound, images or data ]

[ Medical services; advisory medical services and the provision of medical information; dentistry services; advisory services and the provision of information relating to dentistry; advisory services and the provision of information relating to health; consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following the administration of chemical, biological radiological or nuclear materials; ] providing medical information [, consultancy and advisory services ] in the field of pharmaceuticals; medical information in the field of pharmaceuticals; [ dispensing of pharmaceuticals; veterinary services; compilation of medical reports; medical analysis services; medical testing services for diagnostic and treatment purposes; surgical treatment services; advisory services and the provision of medical information relating to surgery; advisory services and the provision of medical information relating to cosmetic surgery; advisory services and the provision of medical information relating to cosmetic treatment; hygienic and beauty care for human beings; hygienic and beauty care for animals; beauty therapy services, namely, medical, hygienic and beauty care services; information, consultancy and advisory services relating to all the aforesaid services; ] information, consultancy and advisory services in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare relating to all the aforesaid services provided on-line

Industrial analysis and research services in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; provision of information relating to medical research, clinical trials, pharmaceutical research and development, and pharmaceutical drug development services; provision of online information relating to medical research, clinical trials, pharmaceutical research and development, and pharmaceutical drug development services; [ design and development of computer software, being software for the provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; design and development of computer software, being software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, Industrial analysis and research services in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; ] provision of information relating to medical research, clinical trials, pharmaceutical research and development, and pharmaceutical drug development services; provision of online information relating to medical research, clinical trials, pharmaceutical research and development, and pharmaceutical drug development services [ ; design and development of computer software, being software for the provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; design and development of computer software, being software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; technological consultancy and advisory services in the technology field of computer hardware and software; computer software design services; technological consultancy, design, testing, research and advisory services, all relating to computing and computer programming; website design services; computer programming; computer systems analysis; computer software design; hosting of websites; technical consultancy and advisory services in the field of computer networks; technical support services, namely, troubleshooting in the nature of diagnosing problems relating to computer hardware, computer software, computer networks and the Internet; computer network design for others, namely, designing on-line services for the search, retrieval, indexing and organisation of data on electronic communication networks and for enhancing the performance and function of such networks; information, consultancy and advisory services relating to all the aforesaid services; information, consultancy and advisory services relating to all the aforesaid services provided on-line ]

[ Education services, namely, providing educational seminars, conferences, classes and workshops in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Training services in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Arranging and conducting of recreation, entertainment, cultural, training and educational conferences, courses, seminars and exhibitions in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; ] Publishing and issuing of scientific papers in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Electronic publishing services, namely, publication of text and graphic works of others online featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; [ the provision of news online in the nature of news agencies, namely, gathering and dissemination of news; ] Non-downloadable electronic publications in the nature of journals, newsletters, reports, and directories in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare via the Internet [ ; providing information and consultation services in connection with the above-mentioned services ]

Filing History

PARTIAL INVALIDATION PROCESSED BY THE IB
Feb 12, 2026 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Dec 22, 2025 INPS
INVALIDATION PROCESSED
Dec 22, 2025 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 6, 2025 INPR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 4, 2025 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Nov 6, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
Nov 6, 2024 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 4, 2024 APRE
TEAS SECTION 71 RECEIVED
Mar 11, 2024 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Dec 2, 2023 NREP
CHANGE OF OWNER RECEIVED FROM IB
Oct 14, 2023 CHLD
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Sep 24, 2022 REM4
INTERNATIONAL REGISTRATION RENEWED
Apr 22, 2021 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Oct 16, 2019 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Oct 16, 2019 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 16, 2019 APRE
TEAS SECTION 71 & 15 RECEIVED
Sep 18, 2019 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 24, 2018 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 8, 2015 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 11, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 21, 2014 FICS
FINAL DISPOSITION PROCESSED
Jan 21, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 24, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 24, 2013 R.PR
NOTIFICATION PROCESSED BY IB
Sep 15, 2013 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 9, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jul 9, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 19, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 19, 2013 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 19, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 4, 2013 PREV
ASSIGNED TO LIE
Jun 4, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 17, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 20, 2013 TEME
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 20, 2013 OPNX
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 19, 2013 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 19, 2013 ERFR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 5, 2013 NREP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 3, 2013 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 3, 2013 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 27, 2012 GNFN
FINAL REFUSAL E-MAILED
Nov 27, 2012 GNFR
FINAL REFUSAL WRITTEN
Nov 27, 2012 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 1, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 31, 2012 TROA
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jun 27, 2012 LIMN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 6, 2012 GNRN
NON-FINAL ACTION E-MAILED
Jun 6, 2012 GNRT
NON-FINAL ACTION WRITTEN
Jun 6, 2012 CNRT
LIMITATION OF GOODS RECEIVED FROM IB
Jun 6, 2012 LIMG
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 25, 2012 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 25, 2012 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 15, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 15, 2012 TROA
ATTORNEY REVIEW COMPLETED
Feb 17, 2012 ATRV
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Feb 17, 2012 LIMS
LIMITATION OF GOODS RECEIVED FROM IB
Feb 3, 2012 LIMG
REFUSAL PROCESSED BY IB
Dec 5, 2011 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 15, 2011 RFCS
APPLICATION FILING RECEIPT MAILED
Nov 15, 2011 MAFR
REFUSAL PROCESSED BY MPU
Nov 14, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 11, 2011 RFCR
NON-FINAL ACTION WRITTEN
Nov 10, 2011 CNRT
ASSIGNED TO EXAMINER
Nov 9, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 9, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 3, 2011 REPR